T. I. Adelusi, “Molecular Docking Assessment of Clinically Approved Antiviral Drugs against Mpro, Spike Glycoprotein and Angiotensin Converting Enzyme-2 Revealed Probable Anti-SARS-CoV-2 Potential: doi.org/10.26538/tjnpr/v5i4.30”, TJNPR, vol. 5, no. 4, pp. 778–791, Mar. 2021, Accessed: Nov. 25, 2024. [Online]. Available: https://tjnpr.org/index.php/home/article/view/677